Doxorubicin-induced cardiotoxicity and risk factors

Doxorubicin (DOX) is an anthracycline antibiotic widely used as a chemotherapeutic agent to treat solid tumours and hematologic malignancies. Although useful in the treatment of cancers, the benefit of DOX is limited due to its cardiotoxic effect that is observed in a large number of patients. In th...

Full description

Bibliographic Details
Published in:	International Journal of Cardiology: Heart & Vasculature
Main Authors:	Carl Belger, Carmelita Abrahams, Aqeela Imamdin, Sandrine Lecour
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Subjects:	Doxorubicin Chemotherapy Toxicity Diabetes Cardiovascular risk
Online Access:	http://www.sciencedirect.com/science/article/pii/S235290672300163X

Similar Items

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Irwin K. Cheah, et al.
Published: (2023-01-01)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
by: Himani Kumari, et al.
Published: (2020-05-01)

Cardiotoxicity of doxorubicin – causes, prevention, prospects
by: Paweł Wesołowski, et al.
Published: (2022-11-01)

The Essential Strategies to Mitigate Cardiotoxicity Caused by Doxorubicin
by: Aleksey Michailovich Chaulin
Published: (2023-10-01)

Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
by: Carmelita Abrahams, et al.
Published: (2022-09-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01)

Evaluation of an Ayurvedic polyherbal formulation (Sindhuvaradi agada) in Doxorubicin induced Cardiotoxicity- in wistar rats
by: Shrutika Subhash Karoshi, et al.
Published: (2018-01-01)

Evaluation of an Ayurvedic polyherbal formulation (Sindhuvaradi agada) in Doxorubicin induced Cardiotoxicity- in wistar rats
by: Shrutika Subhash Karoshi, et al.
Published: (2019-01-01)

Efficacy of amifostine in protection against doxorubicin-induced acute cardiotoxic effects in rats
by: Dragojević-Simić Viktorija, et al.
Published: (2013-01-01)

Doxorubicin-induced cardiotoxicity is mediated by neutrophils through release of neutrophil elastase
by: Anchit Bhagat, et al.
Published: (2022-08-01)

Is the use of anthracyclines implicated in myocardial injury? Investigating the cardio modulatory effects of naringenin and apocynin in doxorubicin-induced cardiotoxicity in rats
by: Justin Atiang Beshel, et al.
Published: (2025-12-01)

Lipidomics application to explain acute cardiotoxicity induced by doxorubicin
by: Lubna Zuhair Abdul Karim, et al.
Published: (2019-12-01)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
by: Sebahat Ulusan, et al.
Published: (2023-05-01)

The cardioprotective properties of Persicaria maculosa and Citrus sinensis extracts against doxorubicin-induced cardiotoxicity in mice
by: Mohammad Zaki, et al.
Published: (2024-07-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review)
by: D. A. Andreev, et al.
Published: (2024-03-01)

Berberine efficacy against Doxorubicin-induced cardiotoxicity: A systematic review
by: Arsalan Khaledifar, et al.
Published: (2023-04-01)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
by: Manrose Singh, et al.
Published: (2022-01-01)

Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future
by: A. M. Chaulin, et al.
Published: (2022-03-01)

Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice
by: Rui Fan, et al.
Published: (2023-08-01)

Doxorubicin‐induced and trastuzumab‐induced cardiotoxicity in mice is not prevented by metoprolol
by: Martin Nicol, et al.
Published: (2021-04-01)

Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism, biomarkers and management
by: Mohd Amaan, et al.
Published: (2024-12-01)

Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
by: Xiaoxiao Lin, et al.
Published: (2023-11-01)

Pathophysiology of Doxorubicin-Mediated Cardiotoxicity
by: Roberto Arrigoni, et al.
Published: (2025-04-01)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
by: Cochera F, et al.
Published: (2018-07-01)

A Versatile PDA(DOX) Nanoplatform for Chemo-Photothermal Synergistic Therapy against Breast Cancer and Attenuated Doxorubicin-Induced Cardiotoxicity
by: Siqi Geng, et al.
Published: (2023-09-01)

Anti-apoptotic effects of minocycline on doxorubicin-induced cardiotoxicity in male Wistar rats
by: Hossein Piri, et al.
Published: (2023-12-01)

Shikimic acid protects against doxorubicin-induced cardiotoxicity in rats
by: Maha Abdullah Alwaili, et al.
Published: (2025-03-01)

The Protective Effect of Metformin Against Doxorubicin Induced Cardiotoxicity in Rabbits
by: Mohammed Hussein shaty, et al.
Published: (2019-03-01)

Cardioprotective potential of protocatechuic acid against doxorubicin-induced cardiotoxicity in rats
by: Leila Safaeian, et al.
Published: (2025-01-01)

CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes
by: Dan Liu, et al.
Published: (2024-09-01)

Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
by: Haixia Xu, et al.
Published: (2020-02-01)

Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update
by: Vasvi Bhutani, et al.
Published: (2025-05-01)

MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
by: Ziyu Kuang, et al.
Published: (2023-03-01)

Characterization of systolic and diastolic function, alongside proteomic profiling, in doxorubicin-induced cardiovascular toxicity in mice
by: Dustin N. Krüger, et al.
Published: (2024-06-01)

The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
by: Rony Abdi Syahputra, et al.
Published: (2022-02-01)

Doxorubicin-induced cardiometabolic disturbances: what can we do?
by: Ashot Avagimyan, et al.
Published: (2025-02-01)

The Role of Nitric Oxide in Doxorubicin-Induced Cardiotoxicity: Experimental Study
by: Ayşenur Bahadır, et al.
Published: (2014-02-01)

Mitophagy in Doxorubicin-Induced Cardiotoxicity: Insights into Molecular Biology and Novel Therapeutic Strategies
by: Heng Zhang, et al.
Published: (2024-12-01)